中国取消限制后,单个中心通过SPECT心肌灌注成像评估COVID-19感染患者的心肌损伤。

IF 2.5 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Keke Xin, Xinghong Ma, Xiaoli Meng, Xiao Zhang, Weidong Yang, Taoqi Ma, Cheng Zhou, Jing Wang, Guoquan Li
{"title":"中国取消限制后,单个中心通过SPECT心肌灌注成像评估COVID-19感染患者的心肌损伤。","authors":"Keke Xin,&nbsp;Xinghong Ma,&nbsp;Xiaoli Meng,&nbsp;Xiao Zhang,&nbsp;Weidong Yang,&nbsp;Taoqi Ma,&nbsp;Cheng Zhou,&nbsp;Jing Wang,&nbsp;Guoquan Li","doi":"10.1007/s12149-024-01970-0","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>To assess myocardial injury using rest single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) in patients with COVID-19 and to evaluate whether myocardial injury detected by rest MPI predict the prognosis of symptoms after 6 months follow-up.</p><h3>Methods</h3><p>Patients suspected of myocarditis between December 2022 and March 2023, after the lifting of COVID-19 pandemic restrictions, and between December 2018 and March 2019, prior to the pandemic, were referred to our study. All patients underwent rest MPI. One hundred and sixty four patients with COVID-19 infection after the lifting of pandemic restrictions and 101 patients before the pandemic were included as the study and control groups, respectively. One hundred and fifty three patients of the study group and 83 of the control group presented symptoms when they initially visit to our department. Compare the parameters of myocardial injury detected by rest SPECT MPI between the two groups and then investigate the association between myocardial injury and symptom prognosis in symptomatic patients of both groups.</p><h3>Results</h3><p>Total perfusion defect (TPD) (4.2% ± 3.3% vs. 2.3% ± 2.2%, <i>P</i> &lt; 0.001), summed rest score (SRS) (5.3 ± 5.4 vs. 2.7 ± 2.0, <i>P</i> &lt; 0.001), the proportion of patients with TPD &gt; 4% (43.3% vs. 17.8%, <i>P</i> &lt; 0.001), TPD &gt; 10% (6.71% vs 0, <i>P</i> &lt; 0.001), SRS &gt; 4 (40.2% vs 15.8%, <i>P</i> &lt; 0.001), SRS &gt; 10 (12.8% vs 0, <i>P</i> &lt; 0.001), the number of abnormal perfusion segments (3.9 ± 3.1 vs. 2.4 ± 1.7, <i>P</i> &lt; 0.001) were all significantly higher in the study group. All the parameters of rest MPI were not associated with the prognosis of symptoms in symptomatic patients of both groups after 6 months follow-up.</p><h3>Conclusion</h3><p>Myocardial injury in COVID-19 patients could be assessed by rest SPECT MPI. The COVID-19 patients could exhibited a higher frequency and greater severity of myocardial injury than uninfected control patients. Myocardial injury assessed by rest MPI did not predict for the prognosis of symptoms in symptomatic patients of both COVID-19 patients and uninfected patients.</p></div>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessment of myocardial injury by SPECT myocardial perfusion imaging in patients with COVID-19 infection in a single center after lifting the restrictions in China\",\"authors\":\"Keke Xin,&nbsp;Xinghong Ma,&nbsp;Xiaoli Meng,&nbsp;Xiao Zhang,&nbsp;Weidong Yang,&nbsp;Taoqi Ma,&nbsp;Cheng Zhou,&nbsp;Jing Wang,&nbsp;Guoquan Li\",\"doi\":\"10.1007/s12149-024-01970-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>To assess myocardial injury using rest single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) in patients with COVID-19 and to evaluate whether myocardial injury detected by rest MPI predict the prognosis of symptoms after 6 months follow-up.</p><h3>Methods</h3><p>Patients suspected of myocarditis between December 2022 and March 2023, after the lifting of COVID-19 pandemic restrictions, and between December 2018 and March 2019, prior to the pandemic, were referred to our study. All patients underwent rest MPI. One hundred and sixty four patients with COVID-19 infection after the lifting of pandemic restrictions and 101 patients before the pandemic were included as the study and control groups, respectively. One hundred and fifty three patients of the study group and 83 of the control group presented symptoms when they initially visit to our department. Compare the parameters of myocardial injury detected by rest SPECT MPI between the two groups and then investigate the association between myocardial injury and symptom prognosis in symptomatic patients of both groups.</p><h3>Results</h3><p>Total perfusion defect (TPD) (4.2% ± 3.3% vs. 2.3% ± 2.2%, <i>P</i> &lt; 0.001), summed rest score (SRS) (5.3 ± 5.4 vs. 2.7 ± 2.0, <i>P</i> &lt; 0.001), the proportion of patients with TPD &gt; 4% (43.3% vs. 17.8%, <i>P</i> &lt; 0.001), TPD &gt; 10% (6.71% vs 0, <i>P</i> &lt; 0.001), SRS &gt; 4 (40.2% vs 15.8%, <i>P</i> &lt; 0.001), SRS &gt; 10 (12.8% vs 0, <i>P</i> &lt; 0.001), the number of abnormal perfusion segments (3.9 ± 3.1 vs. 2.4 ± 1.7, <i>P</i> &lt; 0.001) were all significantly higher in the study group. All the parameters of rest MPI were not associated with the prognosis of symptoms in symptomatic patients of both groups after 6 months follow-up.</p><h3>Conclusion</h3><p>Myocardial injury in COVID-19 patients could be assessed by rest SPECT MPI. The COVID-19 patients could exhibited a higher frequency and greater severity of myocardial injury than uninfected control patients. Myocardial injury assessed by rest MPI did not predict for the prognosis of symptoms in symptomatic patients of both COVID-19 patients and uninfected patients.</p></div>\",\"PeriodicalId\":8007,\"journal\":{\"name\":\"Annals of Nuclear Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-08-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Nuclear Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s12149-024-01970-0\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Nuclear Medicine","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12149-024-01970-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

目的:使用静息单光子发射计算机断层扫描(SPECT)心肌灌注成像(MPI)评估COVID-19患者的心肌损伤,并评估静息MPI检测到的心肌损伤是否能预测随访6个月后症状的预后:在 COVID-19 大流行限制解除后的 2022 年 12 月至 2023 年 3 月期间,以及在大流行之前的 2018 年 12 月至 2019 年 3 月期间,疑似心肌炎患者被转介到我们的研究中。所有患者均接受了静息心动图检查。研究组和对照组分别纳入了 164 名大流行限制解除后感染 COVID-19 的患者和 101 名大流行前感染 COVID-19 的患者。研究组和对照组分别有 153 名和 83 名患者在初诊时出现症状。比较两组患者通过静息 SPECT MPI 检测到的心肌损伤参数,然后研究两组有症状患者的心肌损伤与症状预后之间的关联:总灌注缺损(TPD)(4.2% ± 3.3% vs. 2.3% ± 2.2%,P 4%(43.3% vs. 17.8%),P 10%(6.71% vs. 0),P 4%(40.2% vs. 15.8%),P 10%(12.8% vs. 0),P 结论:COVID 患者的心肌损伤与症状预后密切相关:静息 SPECT MPI 可评估 COVID-19 患者的心肌损伤。与未感染的对照组患者相比,COVID-19 患者的心肌损伤频率更高、程度更严重。通过静息 MPI 评估心肌损伤并不能预测 COVID-19 患者和未感染患者的症状预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Assessment of myocardial injury by SPECT myocardial perfusion imaging in patients with COVID-19 infection in a single center after lifting the restrictions in China

Assessment of myocardial injury by SPECT myocardial perfusion imaging in patients with COVID-19 infection in a single center after lifting the restrictions in China

Purpose

To assess myocardial injury using rest single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) in patients with COVID-19 and to evaluate whether myocardial injury detected by rest MPI predict the prognosis of symptoms after 6 months follow-up.

Methods

Patients suspected of myocarditis between December 2022 and March 2023, after the lifting of COVID-19 pandemic restrictions, and between December 2018 and March 2019, prior to the pandemic, were referred to our study. All patients underwent rest MPI. One hundred and sixty four patients with COVID-19 infection after the lifting of pandemic restrictions and 101 patients before the pandemic were included as the study and control groups, respectively. One hundred and fifty three patients of the study group and 83 of the control group presented symptoms when they initially visit to our department. Compare the parameters of myocardial injury detected by rest SPECT MPI between the two groups and then investigate the association between myocardial injury and symptom prognosis in symptomatic patients of both groups.

Results

Total perfusion defect (TPD) (4.2% ± 3.3% vs. 2.3% ± 2.2%, P < 0.001), summed rest score (SRS) (5.3 ± 5.4 vs. 2.7 ± 2.0, P < 0.001), the proportion of patients with TPD > 4% (43.3% vs. 17.8%, P < 0.001), TPD > 10% (6.71% vs 0, P < 0.001), SRS > 4 (40.2% vs 15.8%, P < 0.001), SRS > 10 (12.8% vs 0, P < 0.001), the number of abnormal perfusion segments (3.9 ± 3.1 vs. 2.4 ± 1.7, P < 0.001) were all significantly higher in the study group. All the parameters of rest MPI were not associated with the prognosis of symptoms in symptomatic patients of both groups after 6 months follow-up.

Conclusion

Myocardial injury in COVID-19 patients could be assessed by rest SPECT MPI. The COVID-19 patients could exhibited a higher frequency and greater severity of myocardial injury than uninfected control patients. Myocardial injury assessed by rest MPI did not predict for the prognosis of symptoms in symptomatic patients of both COVID-19 patients and uninfected patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annals of Nuclear Medicine
Annals of Nuclear Medicine 医学-核医学
CiteScore
4.90
自引率
7.70%
发文量
111
审稿时长
4-8 weeks
期刊介绍: Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine. It develops the appropriate application of radioactive substances and stable nuclides in the field of medicine. The journal promotes the exchange of ideas and information and research in nuclear medicine and includes the medical application of radionuclides and related subjects. It presents original articles, short communications, reviews and letters to the editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信